Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

BACKGROUND: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. METHODS: A Bayesian network meta-analysis was used to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhonghan, Zeng, Kangmei, Zhao, Shen, Zhao, Yuanyuan, Hou, Xue, Luo, Fan, Lu, Feiteng, Zhang, Yaxiong, Zhou, Ting, Ma, Yuxiang, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li, Zhao, Hongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937538/
https://www.ncbi.nlm.nih.gov/pubmed/31908655
http://dx.doi.org/10.1177/1758835919891652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937538/
https://www.ncbi.nlm.nih.gov/pubmed/31908655
http://dx.doi.org/10.1177/1758835919891652

Ejemplares similares